Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT02277743 · COMPLETED
Trial details
- NCT number
- NCT02277743
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-11-01
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.